SPY312.23+1.71 0.55%
DIA258.42+1.11 0.43%
IXIC10,207.63+53.00 0.52%

SunTrust Robinson Humphrey Initiates Coverage On Deciphera Pharmaceuticals with Buy Rating, Announces $77 Price Target

SunTrust Robinson Humphrey analyst Robyn Karnauskas initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy rating and a $77 price target.

Benzinga · -

SunTrust Robinson Humphrey analyst Robyn Karnauskas initiates coverage on Deciphera Pharmaceuticals (NASDAQ:DCPH) with a Buy rating and a $77 price target.